527 related articles for article (PubMed ID: 30723052)
1. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
Hu Q; Tai S; Wang J
Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052
[TBL] [Abstract][Full Text] [Related]
2. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
3. Small nucleolar RNA host gene 1: A new biomarker and therapeutic target for cancers.
Huang L; Jiang X; Wang Z; Zhong X; Tai S; Cui Y
Pathol Res Pract; 2018 Sep; 214(9):1247-1252. PubMed ID: 30107989
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer.
Xu TP; Wang WY; Ma P; Shuai Y; Zhao K; Wang YF; Li W; Xia R; Chen WM; Zhang EB; Shu YQ
Oncogene; 2018 Sep; 37(36):5020-5036. PubMed ID: 29789713
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA FOXD2-AS1 functions as a tumor promoter in colorectal cancer by regulating EMT and Notch signaling pathway.
Yang X; Duan B; Zhou X
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3586-3591. PubMed ID: 28925486
[TBL] [Abstract][Full Text] [Related]
6. FOXD2-AS1 correlates with the malignant status and regulates cell proliferation, migration, and invasion in cutaneous melanoma.
Ren W; Zhu Z; Wu L
J Cell Biochem; 2019 Apr; 120(4):5417-5423. PubMed ID: 30426532
[TBL] [Abstract][Full Text] [Related]
7. Highly expressed long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer progression via Wnt/β-catenin signaling.
Rong L; Zhao R; Lu J
Biochem Biophys Res Commun; 2017 Mar; 484(3):586-591. PubMed ID: 28132805
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA FOXD2-AS1 aggravates nasopharyngeal carcinoma carcinogenesis by modulating miR-363-5p/S100A1 pathway.
Chen G; Sun W; Hua X; Zeng W; Yang L
Gene; 2018 Mar; 645():76-84. PubMed ID: 29248577
[TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
[TBL] [Abstract][Full Text] [Related]
10. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
12. Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of MLH1.
Gao J; Dai C; Yu X; Yin XB; Liao WJ; Huang Y; Zhou F
Gene Ther; 2021 Jun; 28(6):306-318. PubMed ID: 32917950
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
Dong H; Cao W; Xue J
Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA HOXD-AS1 in cancer.
Li L; Wang Y; Zhang X; Huang Q; Diao Y; Yin H; Liu H
Clin Chim Acta; 2018 Dec; 487():197-201. PubMed ID: 30290157
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FOXD2-AS1 induces chondrocyte proliferation through sponging miR-27a-3p in osteoarthritis.
Wang Y; Cao L; Wang Q; Huang J; Xu S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1241-1247. PubMed ID: 30945573
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma through epigenetically silencing CDKN1B(p27) via EZH2.
Xu K; Zhang Z; Qian J; Wang S; Yin S; Xie H; Zhou L; Zheng S
Exp Cell Res; 2019 Jul; 380(2):198-204. PubMed ID: 31004581
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma.
Bao J; Zhou C; Zhang J; Mo J; Ye Q; He J; Diao J
Cancer Biomark; 2018 Feb; 21(3):527-533. PubMed ID: 29286915
[TBL] [Abstract][Full Text] [Related]
19. FOXD2-AS1 acts an oncogene in esophageal squamous cell carcinoma through sponging miR-204-3p.
Luo D; Salai A; Lv H; Wang Y; Gao Y
Clin Transl Oncol; 2022 Oct; 24(10):1954-1963. PubMed ID: 35778646
[TBL] [Abstract][Full Text] [Related]
20. LncRNA FOXD2-AS1 regulates chondrocyte proliferation in osteoarthritis by acting as a sponge of miR-206 to modulate CCND1 expression.
Cao L; Wang Y; Wang Q; Huang J
Biomed Pharmacother; 2018 Oct; 106():1220-1226. PubMed ID: 30119190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]